Clinical Trial Update: Pentoxifylline and Late Onset Sepsis in Preterm Infants [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating pentoxifylline for neonatal late-onset sepsis in preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Late-onset Sepsis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Abd Elazeez Attala Shabaan | Conditions: Neonatal Late Onset Sepsis | Phase 3 | Status: COMPLETED